NASDAQ : ALMS
Alumis Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 6.73 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 871.10M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Alumis Inc. (ALMS) reported revenue of 7.40M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 7.40M | 24.05M | |||
| Gross Profit | 7.40M | 24.05M | |||
| Selling, General & Admin | 83.58M | 85.36M | 35.20M | 20.50M | 12.55M |
| Research & Development | 348.80M | 380.60M | 265.55M | 137.68M | 101.30M |
| Operating Expenses | 432.38M | 465.95M | 300.75M | 158.17M | 113.85M |
| Operating Income | -424.98M | -441.90M | -300.75M | -158.17M | -113.85M |
| Interest & Investment Income | 18.44M | 14.18M | 12.02M | 3.37M | 1.99M |
| Other Non Operating Income (Expenses) | -151.00K | -169.00K | -5.50M | -187.00K | -72.00K |
| EBT Excluding Unusual Items | -406.69M | -427.89M | -294.23M | -154.99M | -111.93M |
| Merger & Restructuring Charges | 7.80M | -11.90M | |||
| Other Unusual Items | 187.91M | ||||
| Pretax Income | -440.71M | -251.89M | -294.23M | -154.99M | -111.93M |
| Income Tax Expense | -1.76M | -8.56M | |||
| Net Income | -438.96M | -243.32M | -294.23M | -154.99M | -111.93M |
| Net Income to Common | -438.96M | -243.32M | -294.23M | -154.99M | -111.93M |
| Shares Outstanding (Basic) | 115.50M | 85.03M | 28.34M | 2.15M | 1.60M |
| Shares Outstanding (Diluted) | 115.50M | 85.03M | 28.34M | 2.15M | 1.60M |
| EPS (Basic) | -3.80 | -2.86 | -10.38 | -72.08 | -69.79 |
| EPS (Diluted) | -3.80 | -2.86 | -10.38 | -72.08 | -69.79 |
| Free Cash Flow | -351.80M | -370.18M | -256.81M | -134.47M | -110.13M |
| Free Cash Flow Per Share | -3.05 | -4.35 | -9.06 | -62.54 | -68.67 |
| Gross Margin | 100.00% | 100.00% | |||
| Operating Margin | -5,744.49% | -1,837.44% | |||
| Profit Margin | -5,933.45% | -1,011.75% | |||
| Free Cash Flow Margin | -4,755.33% | -1,539.19% | |||
| EBITDA | -421.45M | -438.41M | -297.60M | -156.89M | -113.60M |
| D&A For EBITDA | 3.53M | 3.50M | 3.15M | 1.28M | 250.00K |
| EBIT | -424.98M | -441.90M | -300.75M | -158.17M | -113.85M |
| Revenue as Reported | 7.40M | 24.05M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 63.71M | 89.67M | 169.53M | 46.00M | 25.61M |
| Short-Term Investments | 438.59M | 218.83M | 118.74M | 2.96M | 67.25M |
| Cash & Short-Term Investments | 502.29M | 308.50M | 288.26M | 48.95M | 92.86M |
| Other Receivables | 3.86M | 2.08M | 1.81M | 722.00K | 500.00K |
| Receivables | 3.86M | 2.08M | 1.81M | 722.00K | 500.00K |
| Prepaid Expenses | 2.56M | 3.52M | 1.93M | 814.00K | 798.00K |
| Restricted Cash | 82.00K | 113.00K | 206.00K | ||
| Other Current Assets | 5.37M | 4.05M | 14.19M | 2.76M | 8.19M |
| Total Current Assets | 514.08M | 318.23M | 306.19M | 53.36M | 102.56M |
| Property, Plant & Equipment | 34.12M | 35.16M | 33.69M | 35.22M | 4.47M |
| Other Intangible Assets | 9.13M | 50.96M | |||
| Long-Term Deferred Charges | 400.00K | ||||
| Other Long-Term Assets | 3.28M | 7.19M | 1.11M | 1.03M | 1.14M |
| Total Assets | 560.62M | 411.94M | 340.99M | 89.61M | 108.17M |
| Accounts Payable | 12.80M | 10.11M | 9.62M | 1.12M | 1.72M |
| Accrued Expenses | 51.94M | 57.08M | 39.73M | 18.03M | 10.32M |
| Current Portion of Leases | 4.82M | 4.67M | 1.56M | 1.72M | 1.31M |
| Current Unearned Revenue | 6.67M | 1.46M | |||
| Total Current Liabilities | 76.23M | 73.32M | 50.91M | 20.87M | 13.35M |
| Long-Term Leases | 31.61M | 32.24M | 29.16M | 30.86M | 469.00K |
| Long-Term Unearned Revenue | 2.61M | ||||
| Long-Term Deferred Tax Liabilities | 383.00K | 2.14M | |||
| Other Long-Term Liabilities | 239.00K | 330.00K | 813.00K | 1.77M | 4.12M |
| Total Liabilities | 108.46M | 110.64M | 80.89M | 53.50M | 17.94M |
| Common Stock | 12.00K | 10.00K | 5.00K | 1.00K | 1.00K |
| Additional Paid-In Capital | 1.59B | 1.20B | 918.61M | 25.05M | 14.21M |
| Retained Earnings | -1.14B | -901.88M | -658.55M | -364.32M | -209.32M |
| Comprehensive Income & Other | -683.00K | 188.00K | 40.00K | 2.00K | -127.00K |
| Total Common Equity | 452.16M | 301.30M | 260.10M | -339.26M | -195.24M |
| Shareholders' Equity | 452.16M | 301.30M | 260.10M | 36.11M | 90.23M |
| Total Liabilities & Equity | 560.62M | 411.94M | 340.99M | 89.61M | 108.17M |
| Total Debt | 36.43M | 36.91M | 30.72M | 32.58M | 1.78M |
| Net Cash (Debt) | 465.87M | 271.59M | 257.54M | 16.37M | 91.09M |
| Net Cash Per Share | 4.03 | 3.19 | 9.09 | 7.61 | 56.79 |
| Filing Date Shares Outstanding | 129.44M | 127.20M | 54.41M | 2.68M | 1.60M |
| Total Common Shares Outstanding | 128.51M | 104.71M | 54.41M | 2.68M | 1.60M |
| Working Capital | 437.85M | 244.91M | 255.28M | 32.49M | 89.20M |
| Book Value Per Share | 3.52 | 2.88 | 4.78 | -126.78 | -121.74 |
| Tangible Book Value | 443.02M | 250.34M | 260.10M | -339.26M | -195.24M |
| Tangible Book Value Per Share | 3.45 | 2.39 | 4.78 | -126.78 | -121.74 |
| Machinery | 8.49M | 8.45M | 7.83M | 6.18M | 2.41M |
| Construction In Progress | 578.00K | ||||
| Leasehold Improvements | 18.02M | 17.66M | 17.62M | 17.59M | 31.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Net Income | -438.96M | -243.32M | -294.23M | -154.99M | -111.93M |
| Depreciation & Amortization | 3.53M | 3.50M | 3.15M | 1.28M | 250.00K |
| Other Amortization | 555.00K | ||||
| Loss (Gain) From Sale of Assets | 5.00K | 266.00K | |||
| Asset Writedown & Restructuring Costs | 42.80M | 529.00K | 645.00K | ||
| Loss (Gain) From Sale of Investments | -7.18M | -5.30M | -3.69M | -544.00K | -1.04M |
| Stock-Based Compensation | 44.51M | 43.52M | 19.46M | 8.62M | 5.96M |
| Other Operating Activities | 2.17M | -186.21M | 5.47M | 2.13M | 950.00K |
| Change in Accounts Payable | -2.18M | -6.04M | 8.51M | -642.00K | 1.29M |
| Change in Unearned Revenue | 4.06M | 4.07M | |||
| Change in Other Net Operating Assets | 1.62M | 28.29M | 6.25M | 12.70M | -3.21M |
| Operating Cash Flow | -351.40M | -369.52M | -255.08M | -129.97M | -107.72M |
| Capital Expenditures | -401.00K | -653.00K | -1.73M | -4.50M | -2.41M |
| Cash Acquisitions | 49.74M | ||||
| Investment in Securities | -97.54M | 238.79M | -112.06M | 64.97M | -66.34M |
| Investing Cash Flow | -97.94M | 287.88M | -113.79M | 60.47M | -68.75M |
| Issuance of Common Stock | 360.93M | 2.08M | 233.91M | 453.00K | 1.73M |
| Repurchase of Common Stock | -17.00K | -6.00K | -64.00K | ||
| Other Financing Activities | -485.00K | ||||
| Financing Cash Flow | 360.93M | 2.07M | 492.37M | 89.68M | 101.63M |
| Net Cash Flow | -88.41M | -79.58M | 123.50M | 20.18M | -74.85M |
| Free Cash Flow | -351.80M | -370.18M | -256.81M | -134.47M | -110.13M |
| Free Cash Flow Margin | -4,755.33% | -1,539.19% | |||
| Free Cash Flow Per Share | -3.05 | -4.35 | -9.06 | -62.54 | -68.67 |
| Levered Free Cash Flow | -208.64M | -202.33M | -150.41M | -80.50M | |
| Unlevered Free Cash Flow | -208.64M | -202.33M | -150.41M | -80.50M | |
| Change in Working Capital | 1.74M | 17.76M | 14.76M | 12.06M | -1.92M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Market Capitalization | 871.10M | 1.02B | 427.64M | ||
| Enterprise Value | 405.23M | 678.95M | 96.87M | ||
| Last Close Price | 6.73 | 9.76 | 7.86 | ||
| PS Ratio | 117.75 | 42.37 | |||
| PB Ratio | 1.91 | 3.38 | 1.64 | ||
| P/TBV Ratio | 1.97 | 4.07 | 1.64 | ||
| EV/Sales Ratio | 54.78 | 28.23 | |||
| Debt / Equity Ratio | 0.08 | 0.12 | 0.12 | 0.90 | 0.02 |
| Net Debt / Equity Ratio | -1.03 | -0.90 | -0.99 | -0.45 | -1.01 |
| Net Debt / EBITDA Ratio | 1.10 | 0.62 | 0.86 | 0.10 | 0.80 |
| Net Debt / FCF Ratio | 1.32 | 0.73 | 1.00 | 0.12 | 0.83 |
| Asset Turnover | 0.01 | 0.06 | |||
| Quick Ratio | 6.64 | 4.24 | 5.70 | 2.38 | 6.99 |
| Current Ratio | 6.74 | 4.34 | 6.01 | 2.56 | 7.68 |
| Return on Equity (ROE) | -93.65% | -86.69% | -198.66% | -245.36% | |
| Return on Assets (ROA) | -45.34% | -73.36% | -87.31% | -99.97% | |
| Return on Capital Employed (ROCE) | -87.70% | -130.50% | -103.70% | -230.10% | -120.10% |
| Earnings Yield | -56.47% | -23.88% | -68.80% | ||
| FCF Yield | -40.39% | -36.33% | -60.05% | ||
| Buyback Yield / Dilution | -92.95% | -200.01% | -1,218.11% | -34.07% |